MICROSATELLITE STABLE COLORECTAL CANCER
Clinical trials for MICROSATELLITE STABLE COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new MICROSATELLITE STABLE COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for MICROSATELLITE STABLE COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug targets genetic weakness in advanced tumors
Disease control Recruiting nowThis early-stage trial is testing a new drug called FOG-001 for people with advanced or spreading cancers that have specific genetic mutations. Researchers want to find the safest dose and see if the drug can shrink tumors or slow cancer growth. The study will include 575 partici…
Matched conditions: MICROSATELLITE STABLE COLORECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Parabilis Medicines, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for tough cancers: first human trial of experimental drug begins
Disease control Recruiting nowThis study is testing a new drug called BMS-986340 to see if it is safe and can help control advanced cancers. It will be given alone or combined with two other cancer drugs to about 950 people whose cancers have grown despite standard treatments. The main goal is to find the rig…
Matched conditions: MICROSATELLITE STABLE COLORECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC